GENOMIC LANDSCAPE OF METASTATIC HORMONE- NAIVE PROSTATE CANCER

被引:0
|
作者
Mizuno, Kei
Akamatsu, Shusuke
Sumiyoshi, Takayuki
Goto, Takayuki
Kobayashi, Takashi
Yamasaki, Toshinari
Inoue, Takahiro
Fujimoto, Akihiro
Ogawa, Osamu
机构
来源
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP16-17
引用
收藏
页码:E222 / E222
页数:1
相关论文
共 50 条
  • [41] Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer: Comparing definitions of CHAARTED and LATITUDE trial
    Buelens, Sarah
    Poelaert, Filip
    Dhondt, Bert
    Fonteyne, Valerie
    De Visschere, Pieter
    Ost, Piet
    Verbeke, Sofie
    Villeirs, Geert
    De Man, Kathia
    Rottey, Sylvie
    Decaestecker, Karel
    Lumen, Nicolaas
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (04) : 158.e13 - 158.e20
  • [43] Genomic landscape of older versus younger men with metastatic castration-resistant prostate cancer
    Knox, Andrea
    Fettke, Heide
    Hauser, Christine
    Bukczynska, Patricia
    Ng, Nicole
    Foroughi, Siavash
    Graham, Lisa-Jane
    Mahon, Kate
    Tan, Winston
    Zheng, Tiantian
    Yu, Jianjun
    Dai, Chao
    Du, Pan
    Jia, Shidong
    Horvarth, Lisa
    Kohli, Manish
    Azad, Arun
    Kwan, Edmond
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 54 - 55
  • [44] Treatment of Castration-naive Metastatic Prostate Cancer
    Hamilou, Zineb
    Baciarello, Giulia
    Fizazi, Karim
    EUROPEAN UROLOGY FOCUS, 2017, 3 (06): : 518 - 521
  • [45] GENOMIC ALTERATIONS IN PROSTATE CANCER METASTATIC TO THE LIVER
    Lin, Jasmine
    Heard, John
    Ahdoot, Michael
    JOURNAL OF UROLOGY, 2025, 213 (5S):
  • [46] CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IS FEASIBLE IN MEN WITH HORMONE-NAIVE, METASTATIC PROSTATE CANCER (MPCA).
    Heidenreich, Axel
    Karnes, Jeff. R.
    Briganti, Alberto
    Shariat, Shahrokh
    Porres, Daniel
    Fossati, Nicola
    Montorsi, Francesco
    Suardi, Nazareno
    Pfister, David
    JOURNAL OF UROLOGY, 2017, 197 (04): : E721 - E721
  • [47] Chemotherapy in metastatic hormone-naive prostate cancer: Pooled analysis of randomized clinical trials.
    Fabbri, Paolo
    Stocchi, Lucia
    Nicoletti, Stefania
    Drudi, Fabrizio
    Tamburini, Emiliano
    Nicolini, Mario
    Gianni, Lorenzo
    Pasini, Giuseppe
    Montanari, Francesco
    Tassinari, Davide
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [48] The Current Therapeutic Landscape for Metastatic Prostate Cancer
    Bernal, Anastasia
    Bechler, Alivia Jane
    Mohan, Kabhilan
    Rizzino, Angie
    Mathew, Grinu
    PHARMACEUTICALS, 2024, 17 (03)
  • [49] Trends in the use of local intervention for metastatic hormone-naive prostate cancer: A multicenter retrospective study
    Tanaka, Ryuma
    Hatakeyama, Shingo
    Narita, Shintaro
    Sakurai, Toshihiko
    Tanaka, Toshikazu
    Miura, Hikari
    Oishi, Takuya
    Kawamura, Sadafumi
    Hoshi, Senji
    Ishidoya, Shigeto
    Mitsuzuka, Koji
    Ito, Akihiro
    Tsuchiya, Norihiko
    Habuchi, Tomonori
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (11) : 969 - 976
  • [50] In Hormone-Naive Metastatic Prostate Cancer, Should All Patients Now Receive Docetaxel? No, Not Yet
    Armstrong, Andrew J.
    ONCOLOGY-NEW YORK, 2014, 28 (10): : 881 - +